Ignite Creation Date:
2025-12-24 @ 11:37 PM
Ignite Modification Date:
2026-01-05 @ 6:37 PM
Study NCT ID:
NCT02966756
Status:
RECRUITING
Last Update Posted:
2025-12-24
First Post:
2016-11-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Sponsor:
AbbVie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-10-12
Start Date Type:
ACTUAL
Primary Completion Date:
2029-05
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-05
Completion Date Type:
ESTIMATED
First Submit Date:
2016-11-15
First Submit QC Date:
None
Study First Post Date:
2016-11-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-18
Last Update Post Date:
2025-12-24
Last Update Post Date Type:
ACTUAL